Resources Contact Us Home
Ultra-high yield intravenous immune globulin preparation

Image Number 3 for United States Patent #7879331.

An efficacious large-scale alcohol-free plasma fractionation production process which produces a high-yielding, non-denatured, double viral-inactivated intravenous human immune gamma globulin (IgG) product. The process employs sodium citrate in two initial fractionation steps, followed by diafiltration to remove sodium citrate.

  Recently Added Patents
Compositions and processes for forming photovoltaic devices
Control system for an internal combustion engine
Organic electroluminescent element
Superagonistic anti-CD28 antibodies
Petunia plant named `Bartpet001`
Synchronization of communication equipment
Motor device and method of manufacturing the same
  Randomly Featured Patents
Configurable accelerated post-write read to manage errors
Content addressable memory
HgCdTe Bulk doping technique
Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
Integrated circuit package system with L-shaped leadfingers
Process for separating fatty materials from supported nickel catalysts
Sensor device for a household appliance
Chain link for conveyors
Method and apparatus for sorting and counting fish eggs
Multi-chip package